Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors

Neurochemical Research

Volumn 21, Issue 5, 1996, Pages 557-562

  Dreshfield, Laura J ^a   Wong, David T ^a   Perry, Kenneth W ^a   Engleman, Eric A ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Fluoxetine; Hypothalamus; Microdialysis; Pindolol; Serotonin

Indexed keywords

AUTORECEPTOR; FLUOXETINE; PINDOLOL; SEROTONIN; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; DEPRESSION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL; SEROTONIN RELEASE; SEROTONINERGIC NERVE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALYSIS OF VARIANCE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; HYPOTHALAMUS; INFUSIONS, PARENTERAL; KINETICS; MALE; MICRODIALYSIS; PINDOLOL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 0029874903     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02527753     Document Type: Article

References (33)

1. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study. J. Neurochem. 60:776-779.
2. Invernizzi, R., Belli, S., and Samanin, R. 1992. Citalopram's ability to increase extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res. 584:322-324.
3. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Bri. J. Pharmacol. 115:1064-1070.
4. 3H]ketanserin. Eur. J. Pharmacol. 118:13-23.
5. Artigas, F., Perez, V., and Alvarez, E. 1994. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch. Gen. Psychiatry 51:248-251.
6. Blier, P., and Bergeron, R. 1995. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J. Clin. Psychopharm. 15:217-222.
7. 1A receptor. Am. Coll. Neuropsychopharm. 33rd Annual Meeting Abst. P102.
8. 1A antagonists and terminal 5-HT release effects of the combined treatment with 5-HT uptake inhibitors. Ann. Meeting of Soc. for Neurosci. Abstr. 20:1541.
9. Perry, K. W., and Fuller, R. W. 1992. Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sci. 50:1683-1690.
10. Paxinos, G., and Watson, C. 1986. The rat brain in stereotaxic coordinates. Academic Press, London.
11. Perry, K. W., and Fuller, R. W. 1993. Extracellular 5-hydroxytryptamine concentration in rat hypothalamus after administration of fluoxetine plus L-5-hydroxytryptophan. J. Pharm. Pharmacol. 45:759-761.
12. Jacobs, B. L., Fornal, C. A., and Wilkinson, L. O. 1990. Neurophysiological and neurochemical studies of brain serotonergic neurons in behaving animals. Annals of New York Acad. Sci. 600: 260-271.
13. 1A autoreceptors in the regulation of brain 5-HT neuronal activity in behaving cats. IUPHAR satellite meeting on serotonin. Abst. p. 46.
14. 1A receptors potentiates the increase in extracellular monoamines induced by duloxetine in rat hypothalamus. J. Neurochem. 66:599-603.
15. Bel, N., and Artigas, F. 1992. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study [published erratum appears in Eur. J. Pharmacol. 1993, Mar. 2:232(2-3):326]. Eur. J. Pharmacol. 229: 101-103.
16. Wozniak, K., Pert, A., and Linnoila, M. 1992. Alterations in raphe and frontal cortex serotonin over-flow following focal and systemic administration of fluoxetine. Soc. Neurosci. Abst. 18:1525.
17. Guan, X.-M., and McBride, W. J. 1988. Fluoxetine increases the extracellular levels of serotonin in the nucleus accumbens. Brain Res. Bull. 21:43-46.
18. Kalen, P., Strecker, R. E., Rosengren, E. and Bjorklund, A. 1988. Endogenous release of neuronal serotonin and 5-hydroxyindoleacetic acid in the caudate-putamen of the rat as revealed by intracerebral dialysis coupled to high pressure liquid chromatography with fluorimetric detection. J. Neurochem. 51:1422-1435.
19. Kreiss, D. S., and Lucki, I. 1995. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J. Pharmacol. Exp. Ther. 274:866-876.
20. Bel, N., and Artigas, F. 1992. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur. J. Pharmacol. 229:101-103.
21. Tanda, G., Carboni, E., Frau, R., and Di Chiara, G. 1994. Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential. Psychopharmacol. 115:285-288.
22. Rutter, J. J., and Auerbach, S. B. 1993. Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J. Pharmacol. Exp. Ther. 265:1319-1324.
23. Rutter, J. J., Gundlah, C., and Auerbach, S. B. 1995. Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation. Synapse 20:225-233.
24. 1A autoreceptors in the action of selective serotonin uptake inhibitors. Eur. J. Pharmacol. 260:251-255.
25. Hjorth, S., and Carlsson, A. 1986. Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors? Eur. J. Pharmacol. 129:131-138.
26. Hjorth, S., and Sharp, T. 1993. In vivo microdialysis evidence for central serotonin 1A and 1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol. J. Pharmacol. Exp. Ther. 265:707-712.
27. Bosker, F. J., Donker, M. G., Klompmakers, A. A., Kurata, K., and Westenberg, H. G. M. 1994. 5-hydroxytryptamine release in dorsal hippocampus of freely moving rats: modulation by pindolol. Prog. Neuropsychopharmacol. & Biol. Psychiat. 18:765-778.
28. 3H]imipramine localization and relationship to serotonin transporter. J. Pharmacol. Exp. Ther. 252: 410-418.
29. Moret, C. 1985. Pharmacology of the serotonin autoreceptor. Pages 21-49, in Green, A. R. (ed.) Neuropharmacology of Serotonin. Oxford University Press, Oxford.
30. Clemens, J. A., Sawyer, B. D., and Cerimele, B. 1977. Further evidence that serotonin is a neurotransmitter involved in the control of prolactin secretion. Endocrinology 100:692-698.
31. 1A agonist gepirone: electrophysiological studies in the rat brain. Synapse 1: 470-480.
32. Blier, P., Chaput, Y., and de Montigny, C. 1988. Long-term 5-HT reuptake blockade but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain. Naunyn-Schmieleberg's Arch. Pharmacol. 337:246-254.
33. Bel, N., and Artigas, F. 1993. Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15:243-245.